Leigh Syndrome
Symptoms, Doctors, Treatments, Advances & More

Learn About Leigh Syndrome

What is the definition of Leigh Syndrome?

Leigh syndrome is a severe neurological disorder that usually becomes apparent in the first year of life. This condition is characterized by progressive loss of mental and movement abilities (psychomotor regression) and typically results in death within two to three years, usually due to respiratory failure. A small number of individuals do not develop symptoms until adulthood or have symptoms that worsen more slowly.

What are the causes of Leigh Syndrome?

Leigh syndrome can be caused by variants (also called mutations) in one of more than 110 different genes. In humans, most genes are found in DNA in the cell's nucleus, called nuclear DNA. However, some genes are found in DNA in specialized structures in the cell called mitochondria. This type of DNA is known as mitochondrial DNA (mtDNA). While most people with Leigh syndrome have a variant in nuclear DNA, about 20 percent have a variant in mtDNA.

How prevalent is Leigh Syndrome?

Leigh syndrome affects at least 1 in 40,000 newborns. The condition is more common in certain populations. For example, the condition occurs in approximately 1 in 2,000 newborns in the Saguenay Lac-Saint-Jean region of Quebec, Canada and in approximately 1 in 1,700 individuals on the Faroe Islands.

Is Leigh Syndrome an inherited disorder?

Leigh syndrome can have different inheritance patterns. It is most commonly inherited in an autosomal recessive pattern, which means both copies of the gene in each cell must have a variant to cause the disorder. This pattern of inheritance applies to most of the Leigh syndrome-associated genes contained in nuclear DNA, including SURF1. The parents of an individual with an autosomal recessive condition each carry one copy of the altered gene, but they typically do not show signs and symptoms of the condition.

Who are the top Leigh Syndrome Local Doctors?
Elite in Leigh Syndrome
Pediatric Neurology
Elite in Leigh Syndrome
Pediatric Neurology
Referral may be required

Office

100 E Penn Sq Fl 9, 
Philadelphia, PA 
Languages Spoken:
English
Offers Telehealth

Amy Goldstein is a Pediatric Neurologist practicing medicine in Philadelphia, Pennsylvania. Dr. Goldstein is rated as an Elite provider by MediFind in the treatment of Leigh Syndrome. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Kearns-Sayre Syndrome, Leigh Syndrome, MELAS Syndrome, Maternally Inherited Leigh Syndrome, and Gastrostomy. Dr. Goldstein is board certified in American Board Of Psychiatry And Neurology - Psychiatry.

Elite in Leigh Syndrome
Elite in Leigh Syndrome
Referral may be required
Montreal, QC, CA 

Christine Des Rosiers practices practicing medicine in Montreal, Canada. Ms. Des Rosiers is rated as an Elite expert by MediFind in the treatment of Leigh Syndrome. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Leigh Syndrome, Cytochrome C Oxidase Deficiency, Lactic Acidosis, and Dihydrolipoamide Dehydrogenase Deficiency.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Leigh Syndrome
Elite in Leigh Syndrome
Referral may be required
Barcelona, CT, ES 

Elisenda Sanz practices practicing medicine in Barcelona, Spain. Sanz is rated as an Elite expert by MediFind in the treatment of Leigh Syndrome. They are also highly rated in 2 other conditions, according to our data. Their clinical expertise encompasses Leigh Syndrome, Mitochondrial Complex 1 Deficiency, Hypotonia, and Osteoporosis.

What are the latest Leigh Syndrome Clinical Trials?
The NIH Mini Study: Metabolism, INfection and Immunity in Inborn Errors of Mitochondrial Metabolism

Summary: The Metabolism, Infection and Immunity (MINI) Study is a longitudinal natural history study at the National Institutes of Health (NIH) that aims to define the relationship between infection, immunity and clinical decline in individuals with mitochondrial disease. Mitochondrial diseases are a group of disorders caused by problems with the cell s ability to produce energy. Infection in individuals w...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Global Mitochondrial Registry to Define Natural History and Outcome Measures to Achieve Definite Trial Readiness for Mitochondrial Disorders

Summary: The main goal of the project is provision of a global registry for mitochondrial disorders to harmonize previous national registries, enable world-wide participation and facilitate natural history studies, definition of outcome measures and conduction of clinical trials.

Who are the sources who wrote this article ?

Published Date: April 28, 2023
Published By: National Institutes of Health